{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:12:45Z","timestamp":1792084365477,"version":"4.4.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1124\/jpet.103.058149","type":"journal-article","created":{"date-parts":[[2004,2,25]],"date-time":"2004-02-25T22:12:55Z","timestamp":1077747175000},"page":"857-864","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["The Role of the Interchain Disulfide Bond in Governing the Pharmacological Actions of Botulinum Toxin"],"prefix":"10.1016","volume":"308","author":[{"given":"Lance L.","family":"Simpson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew B.","family":"Maksymowych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Beak","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roop S.","family":"Bora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.103.058149_bib1","doi-asserted-by":"crossref","unstructured":"Ahmed SA and Smith LA (2000) Light chain of botulinum A neurotoxin expressed as an inclusion body from a synthetic gene is catalytically and functionally active. J Prot Chem 19: 475\u2013487.","DOI":"10.1023\/A:1026549431380"},{"key":"10.1124\/jpet.103.058149_bib2","doi-asserted-by":"crossref","unstructured":"DasGupta BR and SathyamoorthyV (1984) Purification and amino acid composition of type A botulinum neurotoxin. Toxicon 22: 415\u2013424.","DOI":"10.1016\/0041-0101(84)90085-0"},{"key":"10.1124\/jpet.103.058149_bib3","doi-asserted-by":"crossref","unstructured":"DasGupta BR and Sugiyama H (1972) A common subunit structure in Clostridium botulinum type A, B and E toxins. Biochem Biophy Res Commun 48: 108\u2013112.","DOI":"10.1016\/0006-291X(72)90350-6"},{"key":"10.1124\/jpet.103.058149_bib4","doi-asserted-by":"crossref","unstructured":"de Paiva A, Poulain B, Lawrence GW, Shone CC, Tauc L, and Dolly JO (1993) A role for the interchain disulfide or its participating thiols in the internalization of botulinum neurotoxin A revealed by a toxin derivative that binds to ecto-acceptors and inhibits transmitter release. J Biol Chem 268: 20838\u201320844.","DOI":"10.1016\/S0021-9258(19)36861-9"},{"key":"10.1124\/jpet.103.058149_bib5","unstructured":"Herreros J, Lalli G, Montecucco C, and Schiavo G (1999) Pathophysiological properties of clostridial neurotoxins, in Comprehensive Sourcebook of Bacterial Protein Toxins (Alouf JE and Freer JH eds) pp 202\u2013228, Academic Press, New York."},{"key":"10.1124\/jpet.103.058149_bib6","doi-asserted-by":"crossref","unstructured":"Humeau Y, Doussau F, Grant NJ, and Poulain B (2000) How botulism and tetanus neurotoxins block neurotransmitter release. Biochimie 82: 427\u2013446.","DOI":"10.1016\/S0300-9084(00)00216-9"},{"key":"10.1124\/jpet.103.058149_bib7","doi-asserted-by":"crossref","unstructured":"Kiyatkin N, Maksymowych AB, and Simpson LL (1997) Induction of an immune response by oral administration of recombinant botulinum toxin. Infect Immun 65: 4586\u20134591.","DOI":"10.1128\/iai.65.11.4586-4591.1997"},{"key":"10.1124\/jpet.103.058149_bib8","doi-asserted-by":"crossref","unstructured":"Lacy DB, Tepp W, Cohen AC, DasGupta BR, and Stevens RC (1998) Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat Struct Biol 5: 898\u2013902.","DOI":"10.1038\/2338"},{"key":"10.1124\/jpet.103.058149_bib9","doi-asserted-by":"crossref","unstructured":"Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond) 227: 680\u2013685.","DOI":"10.1038\/227680a0"},{"key":"10.1124\/jpet.103.058149_bib10","doi-asserted-by":"crossref","unstructured":"Poirier M, Hao J, Malkus P, Chan C, Moore M, King D, and Bennett M (1998) Protease resistance of syntaxin \u00b7 SNAP-25 \u00b7 VAMP complexes. J Biol Chem 273: 11370\u201311377.","DOI":"10.1074\/jbc.273.18.11370"},{"key":"10.1124\/jpet.103.058149_bib11","doi-asserted-by":"crossref","unstructured":"Sakaguchi G (1982) Clostridium botulinum toxins. Pharmacol Ther 19: 165\u2013194.","DOI":"10.1016\/0163-7258(82)90061-4"},{"key":"10.1124\/jpet.103.058149_bib12","doi-asserted-by":"crossref","unstructured":"Sch\u00e4gger H and Von Jagow G (1987) Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 166: 368\u2013379.","DOI":"10.1016\/0003-2697(87)90587-2"},{"key":"10.1124\/jpet.103.058149_bib13","doi-asserted-by":"crossref","unstructured":"Schiavo G, Matteoli M, and Montecucco C (2000) Neurotoxins affecting neuroexocytosis. Physiol Rev 80: 717\u20137663.","DOI":"10.1152\/physrev.2000.80.2.717"},{"key":"10.1124\/jpet.103.058149_bib14","doi-asserted-by":"crossref","unstructured":"Schiavo G, Papini E, Genna G, and Montecucco C (1990) An intact interchain disulfide bond is required for the neurotoxicity of tetanus toxin. Infect Immun 58: 4136\u20134141.","DOI":"10.1128\/iai.58.12.4136-4141.1990"},{"key":"10.1124\/jpet.103.058149_bib15","doi-asserted-by":"crossref","unstructured":"Siegel LS (1988) Human immune response to a pentavalent (ABCDE) toxoid determined by a neutralization test and by an enzyme-linked immunosorbent assay. J Clin Microbiol 26: 2351\u20132356.","DOI":"10.1128\/jcm.26.11.2351-2356.1988"},{"key":"10.1124\/jpet.103.058149_bib16","doi-asserted-by":"crossref","unstructured":"Simpson LL (2004) Identification of the major steps in botulinum toxin action. Ann Rev Pharmacol Toxicol, in press.","DOI":"10.1146\/annurev.pharmtox.44.101802.121554"},{"key":"10.1124\/jpet.103.058149_bib17","doi-asserted-by":"crossref","unstructured":"Simpson LL and DasGupta BR (1983) Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships. J Pharmacol Exp Ther 224: 135\u2013140.","DOI":"10.1016\/S0022-3565(25)33441-5"},{"key":"10.1124\/jpet.103.058149_bib18","doi-asserted-by":"crossref","unstructured":"Simpson LL, Maksymowych AB, and Kiyatkin N (1999) Botulinum toxin as a carrier for oral vaccines. Cell Mol Life Sci 56: 47\u201361.","DOI":"10.1007\/s000180050005"},{"key":"10.1124\/jpet.103.058149_bib19","doi-asserted-by":"crossref","unstructured":"Simpson LL, Schmidt JJ, and Middlebrook JL (1988) Isolation and characterization of botulinum neurotoxins. Methods Enzymol 165: 76\u201385.","DOI":"10.1016\/S0076-6879(88)65015-4"},{"key":"10.1124\/jpet.103.058149_bib20","doi-asserted-by":"crossref","unstructured":"Swaminathan S and Eswaramoorthy S (2000) Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B. Nat Struct Biol 7: 693\u2013699.","DOI":"10.1038\/78005"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524311966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524311966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.103.058149","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:47:27Z","timestamp":1739998047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524311966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0022356524311966"],"URL":"https:\/\/doi.org\/10.1124\/jpet.103.058149","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of the Interchain Disulfide Bond in Governing the Pharmacological Actions of Botulinum Toxin","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.103.058149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2004 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}